SINOPHARM TECH(08156): Possible delay in publishing 2024 annual performance.

Sinopharm Tech (08156) announced that due to the possible replacement of the group's auditor, the annual performance announcement for the fiscal year ending June 30, 2024 (2024 annual performance) may be delayed. According to recent communication between PwC and the company, PwC may resign from its position as the group's auditor due to limited internal resources. The board of directors is currently searching for a suitable replacement to fill the temporary vacancy that may arise from PwC's resignation. Although the delay in the publication of the 2024 annual performance will constitute a violation of Rule 18.49 of the GEM Listing Rules, the board of directors hereby emphasizes that the group's operations are continuing as normal and that the company will make every effort to publish the 2024 annual performance to shareholders as soon as possible.